Very Early PCSK9 Inhibition for Acute Myocardial Infarction

NCT07208006 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

1518

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction (AMI)

Interventions

DRUG: Standard Lipid-Lowering Therapy
DRUG: Early Intensive Lipid-Lowering Therapy (PCSK9 Inhibitor)

Sponsor

Shanghai Zhongshan Hospital